🎉 M&A multiples are live!
Check it out!

VSee Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for VSee Health and similar public comparables like Doctor Care Anywhere, UniDoc Health, and Kooth.

VSee Health Overview

About VSee Health

VSee Health Inc is a telehealth software platform. VSee’s telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.


Founded

2010

HQ

United States of America
Employees

119

Website

vsee.com

Financials

LTM Revenue $12.8M

LTM EBITDA -$2.7M

EV

$27.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

VSee Health Financials

VSee Health has a last 12-month revenue (LTM) of $12.8M and a last 12-month EBITDA of -$2.7M.

In the most recent fiscal year, VSee Health achieved revenue of $6.4M and an EBITDA of -$1.6M.

VSee Health expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See VSee Health valuation multiples based on analyst estimates

VSee Health P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $12.8M XXX $6.4M XXX XXX XXX
Gross Profit $9.1M XXX $4.8M XXX XXX XXX
Gross Margin 71% XXX 76% XXX XXX XXX
EBITDA -$2.7M XXX -$1.6M XXX XXX XXX
EBITDA Margin -21% XXX -25% XXX XXX XXX
EBIT -$37.6M XXX -$1.5M XXX XXX XXX
EBIT Margin -294% XXX -23% XXX XXX XXX
Net Profit -$34.5M XXX -$0.8M XXX XXX XXX
Net Margin -270% XXX -13% XXX XXX XXX
Net Debt XXX XXX $0.3M XXX XXX XXX

Financial data powered by Morningstar, Inc.

VSee Health Stock Performance

As of May 30, 2025, VSee Health's stock price is $1.

VSee Health has current market cap of $19.9M, and EV of $27.9M.

See VSee Health trading valuation data

VSee Health Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$27.9M $19.9M XXX XXX XXX XXX $-0.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

VSee Health Valuation Multiples

As of May 30, 2025, VSee Health has market cap of $19.9M and EV of $27.9M.

VSee Health's trades at 4.4x EV/Revenue multiple, and -17.6x EV/EBITDA.

Equity research analysts estimate VSee Health's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

VSee Health has a P/E ratio of -0.6x.

See valuation multiples for VSee Health and 12K+ public comps

VSee Health Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $19.9M XXX $19.9M XXX XXX XXX
EV (current) $27.9M XXX $27.9M XXX XXX XXX
EV/Revenue 2.2x XXX 4.4x XXX XXX XXX
EV/EBITDA -10.2x XXX -17.6x XXX XXX XXX
EV/EBIT -0.7x XXX -19.1x XXX XXX XXX
EV/Gross Profit 3.1x XXX n/a XXX XXX XXX
P/E -0.6x XXX -23.8x XXX XXX XXX
EV/FCF -7.9x XXX -33.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get VSee Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

VSee Health Margins & Growth Rates

VSee Health's last 12 month revenue growth is 46%

VSee Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

VSee Health's rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

VSee Health's rule of X is 93% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for VSee Health and other 12K+ public comps

VSee Health Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 46% XXX 84% XXX XXX XXX
EBITDA Margin -21% XXX -25% XXX XXX XXX
EBITDA Growth 18% XXX n/a XXX XXX XXX
Rule of 40 51% XXX 21% XXX XXX XXX
Bessemer Rule of X XXX XXX 93% XXX XXX XXX
Revenue per Employee XXX XXX $0.1M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 99% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

VSee Health Public Comps

See public comps and valuation multiples for Telemedicine & Virtual Care and Healthcare Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Doctor Care Anywhere XXX XXX XXX XXX XXX XXX
UniDoc Health XXX XXX XXX XXX XXX XXX
Ping An Healthcare XXX XXX XXX XXX XXX XXX
Kooth XXX XXX XXX XXX XXX XXX
Atrys Health XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

VSee Health M&A and Investment Activity

VSee Health acquired  XXX companies to date.

Last acquisition by VSee Health was  XXXXXXXX, XXXXX XXXXX XXXXXX . VSee Health acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by VSee Health

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About VSee Health

When was VSee Health founded? VSee Health was founded in 2010.
Where is VSee Health headquartered? VSee Health is headquartered in United States of America.
How many employees does VSee Health have? As of today, VSee Health has 119 employees.
Who is the CEO of VSee Health? VSee Health's CEO is Mr. Milton Chen.
Is VSee Health publicy listed? Yes, VSee Health is a public company listed on NAS.
What is the stock symbol of VSee Health? VSee Health trades under VSEE ticker.
When did VSee Health go public? VSee Health went public in 2024.
Who are competitors of VSee Health? Similar companies to VSee Health include e.g. Doctor Care Anywhere, UniDoc Health, Ping An Healthcare, Kooth.
What is the current market cap of VSee Health? VSee Health's current market cap is $19.9M
What is the current revenue of VSee Health? VSee Health's last 12 months revenue is $12.8M.
What is the current revenue growth of VSee Health? VSee Health revenue growth (NTM/LTM) is 46%.
What is the current EV/Revenue multiple of VSee Health? Current revenue multiple of VSee Health is 2.2x.
Is VSee Health profitable? Yes, VSee Health is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of VSee Health? VSee Health's last 12 months EBITDA is -$2.7M.
What is VSee Health's EBITDA margin? VSee Health's last 12 months EBITDA margin is -21%.
What is the current EV/EBITDA multiple of VSee Health? Current EBITDA multiple of VSee Health is -10.2x.
What is the current FCF of VSee Health? VSee Health's last 12 months FCF is -$3.5M.
What is VSee Health's FCF margin? VSee Health's last 12 months FCF margin is -28%.
What is the current EV/FCF multiple of VSee Health? Current FCF multiple of VSee Health is -7.9x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.